BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 26428602)

  • 1. Update on the epidemiology, diagnosis, and treatment of leprosy.
    Reibel F; Cambau E; Aubry A
    Med Mal Infect; 2015 Sep; 45(9):383-93. PubMed ID: 26428602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug therapy for leprosy: a game changer on the path to elimination.
    Smith CS; Aerts A; Saunderson P; Kawuma J; Kita E; Virmond M
    Lancet Infect Dis; 2017 Sep; 17(9):e293-e297. PubMed ID: 28693853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S; Courtright P
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract]   [Full Text] [Related]  

  • 6. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leprosy.
    Indian J Med Sci; 2001 May; 55(5):275-7. PubMed ID: 11641922
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 11. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on leprosy.
    Marlowe SN; Lockwood DN
    Hosp Med; 2001 Aug; 62(8):471-6. PubMed ID: 11530584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of leprosy: epidemiology, basic science and clinical perspectives.
    Suzuki K; Akama T; Kawashima A; Yoshihara A; Yotsu RR; Ishii N
    J Dermatol; 2012 Feb; 39(2):121-9. PubMed ID: 21973237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of drugs for activity against Mycobacterium leprae.
    Baohong J; Matsuo Y; Colston MJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
    [No Abstract]   [Full Text] [Related]  

  • 15. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
    Soares DJ; Neupane K; Britton WJ
    Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leprosy – an old infectious disease with unsolved matters].
    Stock I
    Med Monatsschr Pharm; 2016 Dec; 39(12):522-6. PubMed ID: 29979513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
    Cambau E; Saunderson P; Matsuoka M; Cole ST; Kai M; Suffys P; Rosa PS; Williams D; Gupta UD; Lavania M; Cardona-Castro N; Miyamoto Y; Hagge D; Srikantam A; Hongseng W; Indropo A; Vissa V; Johnson RC; Cauchoix B; Pannikar VK; Cooreman EAWD; Pemmaraju VRR; Gillini L;
    Clin Microbiol Infect; 2018 Dec; 24(12):1305-1310. PubMed ID: 29496597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in leprosy: An update following 70years of chemotherapy.
    Aubry A; Sammarco Rosa P; Chauffour A; Fletcher ML; Cambau E; Avanzi C
    Infect Dis Now; 2022 Aug; 52(5):243-251. PubMed ID: 35483633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis and treatment of leprosy.
    Katoch VM
    Expert Rev Mol Med; 2002 Jul; 4(15):1-14. PubMed ID: 14585155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.